The Korean pharmaceutical industry is expected to recover next year… various restrictions will be finalized soon
The Korean pharmaceutical industry, which had a huge hit by the across-the-nation drug price reduction in 2012, is expected to recover with single-digit increases next year.
Based on the ‘2015 Major Pharmaceutical Companies Performance Prospect’ data that Hana Daetoo Securities released on the 2...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
